Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.5B | 14.2B | 13.0B | 13.6B |
| Cost of revenue | 11.4B | 10.0B | 9.4B | 9.4B |
| Gross profit | 5.1B | 4.2B | 3.6B | 4.3B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 191M | 630M | 186M | 164M |
| Other operating expenses | 117M | 71M | 70M | 102M |
| Operating income | 4.2B | 3.0B | 2.9B | 3.5B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 299M | 276M | 269M | 278M |
| Other income expense | 547M | -123M | 593M | 475M |
| Pretax income | 4.5B | 3.0B | 3.2B | 3.7B |
| Tax provision | 1.6B | 664M | 1.2B | 1.3B |
| Net income | 2.8B | 2.3B | 2.1B | 2.3B |
| Basic EPS | 0.2 | 0.2 | 0.1 | 0.2 |
| Diluted EPS | 0.2 | 0.2 | 0.1 | 0.2 |
| Basic average shares | 2.7B | 2.5B | 2.5B | 2.5B |
| Diluted average shares | 2.7B | 2.6B | 2.5B | 2.5B |
| EBITDA | 7.5B | 6.0B | 5.9B | 6.3B |
| Net income from continuing op. | 2.8B | 2.3B | 2.1B | 2.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 9M | — | — | 7M |